News Briefing SchedulePress Office Hours and LocationAbstracts and Embargo PolicyPress Policies and Registration FormInstitutional Virtual Press Room
The 2017 Multidisciplinary Thoracic Cancers Symposium will provide participants with updates on current early phase clinical and translational initiatives in thoracic malignancies, including targeted therapy, immunotherapy, advanced radiation and surgical methodologies, and pathological advancements in molecular categorization that are relevant to daily clinical practice. Additionally, attendees will be updated on the appropriate integration of all the advancements in their daily practice, including indication, patient selection, combinations of different therapeutic modalities, prevention and management of common toxicities.
This two-and-a-half day meeting will feature interactive case discussions; educational sessions on new multidisciplinary therapies, new targeted therapies, immunotherapy, treatment and screening guidelines, and supportive care; and oral abstract sessions highlighting the most current, evidence-based practices.
News briefings will highlight top research studies presented at the 2017 Multidisciplinary Thoracic Cancers Symposium. Registered press working remotely will be able to access live audio and slides from the news briefings and ask questions virtually. All presenter slides and an audio recording will be posted here following each briefing.
Advanced Predictors and Targeted TherapiesThursday, March 16, 2017, 12:30 – 1:15 p.m. Pacific time
Moderator: Ravi Salgia, MD, PhD, City of Hope
Treatment Considerations for Focused PopulationsFriday, March 17, 2017, 1:00 – 1:45 p.m. Pacific time
Moderator: Pranshu Mohindra, MD, University of Maryland, Baltimore
There will be an on-site press office in the Foothill F room of the San Francisco Marriott Marquis open Thursday, March 16 and Friday, March 17 from 8:00 a.m. to 4:00 p.m. Pacific time.
Questions about the press program and press office may be directed to ASTRO’s media relations team.
All abstracts to be presented at the 2017 Multidisciplinary Thoracic Cancers Symposium are embargoed until 8:00 a.m. Pacific time on Thursday, March 16, 2017. The embargo policy applies to all abstracts regardless of whether information is obtained from another source. Failure to abide by this embargo policy may result in suspension of press credentials at the 2017 Multidisciplinary Thoracic Cancers Symposium as well as future ASTRO meetings. Questions about the embargo policy may be directed to ASTRO’s media relations team.
The full text of the abstracts selected for oral and poster presentation will be available online at the start of the symposium.
Complimentary registration is available for professional journalists representing media organizations for the express purpose of gathering news and information to produce press coverage of the Symposium. Complimentary registration is open to representatives of print, broadcast and Web-based media, including health care trade media (collectively known as press), as well as public information officers from educational institutions, government agencies and nonprofit cancer research organizations presenting research at the 2017 Multidisciplinary Thoracic Cancers Symposium.
Press Registration Form
To register as press, journalists must submit a completed press registration form and additional information as specified below:
For medical publishing companies, the publication must meet the following criteria to obtain press access:
For online news outlets (including blogs), the news-making organization or private blog must meet the following criteria to obtain press access:
Public relations, marketing and/or advertising representatives, financial analysts, book publishers and book authors, and individuals from communications, print or online promotion services are welcome to register as regular attendees, however, they are not permitted to register as press.
ASTRO reserves the right to bar from this and future meetings any journalist who fails to adhere to these policies or who misuses his/her press privileges to engage in activities other than journalistic pursuits.
ASTRO provides an exclusive virtual press room for academic, public and private institutions presenting research at the 2017 Multidisciplinary Thoracic Cancers Symposium. The Institutional Virtual Press Room is the online gateway to the on- and off-site reporters who are covering the meeting. Please note that there is not a physical, on-site press room for institutions, and printed materials will not be accepted for distribution. Email ASTRO’s media relations team with any questions about the Institutional Virtual Press Room or to submit materials for inclusion.